Walter Krebs - Chemed Corp Independent Director
| CHE Stock | USD 597.42 6.75 1.12% |
Director
Mr. Walter L. Krebs serves as an Independent Director of the Company since 2005.
| Age | 85 |
| Tenure | 19 years |
| Address | 255 East Fifth Street, Cincinnati, OH, United States, 45202-4726 |
| Phone | 513 762 6690 |
| Web | https://www.chemed.com |
Chemed Corp Management Efficiency
The company has Return on Asset of 0.1378 % which means that on every $100 spent on assets, it made $0.1378 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2859 %, implying that it generated $0.2859 on every 100 dollars invested. Chemed Corp's management efficiency ratios could be used to measure how well Chemed Corp manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Assets is expected to grow to 0.16, whereas Return On Tangible Assets are forecasted to decline to 0.14. At present, Chemed Corp's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 525.9 M, whereas Other Current Assets are forecasted to decline to about 31.9 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| David DArgenio | Simulations Plus | 64 | |
| Michael DAmato | Evolent Health | 66 | |
| Bridget Duffy | Evolent Health | 60 | |
| Diane Patrick | Agiliti | 69 | |
| Norman Payson | Evolent Health | 69 | |
| Allen Moseley | Streamline Health Solutions | 46 | |
| Dale Polley | HealthStream | 67 | |
| David Farner | Evolent Health | 56 | |
| Martiny Harris | HealthStream | 59 | |
| Bruce Felt | Evolent Health | 61 | |
| Michael Valentine | Streamline Health Solutions | 47 | |
| Linda Rebrovick | HealthStream | 62 | |
| Michael Shmerling | HealthStream | 62 | |
| Kenan Lucas | Streamline Health Solutions | 33 | |
| Thompson Dent | HealthStream | 68 | |
| Judith Starkey | Streamline Health Solutions | 69 | |
| Frank Gordon | HealthStream | 55 | |
| Robert Musslewhite | Evolent Health | 44 | |
| Jeffrey McLaren | HealthStream | 51 | |
| Daniel Weiner | Simulations Plus | 66 | |
| Michael Kaplan | Streamline Health Solutions | 50 | |
Management Performance
| Return On Equity | 0.29 | ||||
| Return On Asset | 0.14 |
Chemed Corp Leadership Team
Elected by the shareholders, the Chemed Corp's board of directors comprises two types of representatives: Chemed Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemed. The board's role is to monitor Chemed Corp's management team and ensure that shareholders' interests are well served. Chemed Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemed Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Naomi Dallob, Vice President and the Secretary and Chief Legal Officer | ||
| David Williams, Chief Financial Officer, Executive Vice President | ||
| Andrea Lindell, Independent Director | ||
| George Walsh, Independent Chairman of the Board | ||
| Thomas Rice, Independent Director | ||
| Joel Gemunder, Independent Director | ||
| Sherri Warner, Director Relations | ||
| Patrick Grace, Independent Director | ||
| Frank Wood, Independent Director | ||
| Timothy OToole, Executive VP and CEO of Vitas | ||
| Thomas Hutton, VP Director | ||
| Nicholas Westfall, Executive Vice President | ||
| Christopher Heaney, Independent Director | ||
| Kevin McNamara, President, Chief Executive Officer, Director | ||
| Arthur Tucker, Principal Accounting Officer, VP and Controller | ||
| Spencer Lee, Executive Vice President | ||
| Ron DeLyons, Independent Director | ||
| Donald Saunders, Independent Director | ||
| Michael Witzeman, Principal Accounting Officer, Controller | ||
| Lisa Reinhard, Chief VP | ||
| Brian Judkins, Vice President Chief Legal Officer, Secretary | ||
| Walter Krebs, Independent Director |
Chemed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemed Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.29 | ||||
| Return On Asset | 0.14 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 8.91 B | ||||
| Shares Outstanding | 15.14 M | ||||
| Shares Owned By Insiders | 2.39 % | ||||
| Shares Owned By Institutions | 97.70 % | ||||
| Number Of Shares Shorted | 451.55 K | ||||
| Price To Earning | 25.42 X |
Pair Trading with Chemed Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemed Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemed Corp will appreciate offsetting losses from the drop in the long position's value.Moving together with Chemed Stock
| 0.82 | ELMD | Electromed | PairCorr |
| 0.88 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.75 | BAX | Baxter International Financial Report 25th of April 2024 | PairCorr |
Moving against Chemed Stock
| 0.76 | IVP | Inspire Veterinary | PairCorr |
| 0.75 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
| 0.73 | MMSI | Merit Medical Systems Financial Report 24th of April 2024 | PairCorr |
| 0.56 | NVST | Envista Holdings Corp Financial Report 1st of May 2024 | PairCorr |
| 0.55 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chemed Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemed Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemed Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemed Corp to buy it.
The correlation of Chemed Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemed Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemed Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemed Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemed Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.Note that the Chemed Corp information on this page should be used as a complementary analysis to other Chemed Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Chemed Stock analysis
When running Chemed Corp's price analysis, check to measure Chemed Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemed Corp is operating at the current time. Most of Chemed Corp's value examination focuses on studying past and present price action to predict the probability of Chemed Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemed Corp's price. Additionally, you may evaluate how the addition of Chemed Corp to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Chemed Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemed Corp. If investors know Chemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemed Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.432 | Dividend Share 1.56 | Earnings Share 17.94 | Revenue Per Share 150.46 | Quarterly Revenue Growth 0.072 |
The market value of Chemed Corp is measured differently than its book value, which is the value of Chemed that is recorded on the company's balance sheet. Investors also form their own opinion of Chemed Corp's value that differs from its market value or its book value, called intrinsic value, which is Chemed Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemed Corp's market value can be influenced by many factors that don't directly affect Chemed Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemed Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemed Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemed Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.